GOLPH3 and non-small cell lung carcinoma: Although quite a number of studies have investigated the clinical role of GOLPH3 in NSCLC and indicated that GOLPH3 could be a risk factor and prognostic biomarker for NSCLC, the relationships of GOLPH3 expression with clinicopathologic features in patients with NSCLC are inconsistent and controversial.